CONTROL MECHANISM OF RADIORESISTANT HYPOXIC CELLS IN MUTICELLULAR TUMOR SPHEROIDS
CONTROL MECHANISM OF RADIORESISTANT HYPOXIC CELLS IN MUTICELLULAR TUMOR SPHEROIDS
批准号:
10470399
负责人:
SASAKI Takehito
金额:
$7.17万
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (B).
财政年份:
1998
资助国家:
日本
项目状态:
已结题
起止时间:
1998 至 2000
中文摘要
本研究建立了含人胰岛素样生长因子-IR基因(A7(R))的人胶质母细胞瘤细胞(A-7),或与仅含有嘌呤霉素抗性基因的A7(Puro)共转染的人胶质母细胞瘤细胞(A-7)。IGF-IR过表达导致A7(R)球体坏死区消失,而A7(Puro)细胞球体呈中央坏死。结合A7(R)细胞球体内较快的生长速度,提示IGF-IR高表达细胞构成的肿瘤生长较快,坏死率较低。然而,球体中的A7(R)细胞表现出比A7(Puro)细胞更高的放射敏感性,并且这种辐射敏感性依赖于剂量分数的大小。用IGF-IR(R-)基因敲除小鼠的成纤维细胞和转染人IGF-IR基因的细胞(R+)研究了严重缺氧细胞中IGF-IR的作用。在氧分压低于3 mm Hg的低氧条件下,(R+)细胞比(R-)细胞存活时间更长,在低氧条件下比(R-)细胞更耐受辐射。(R+)生长在融合状态的细胞在短时间内从培养皿表面脱落,这表明在严重缺氧条件下,这些细胞倾向于迅速死亡,这取决于细胞密度。
英文摘要
Human glioblastoma cells(A-7)transfected with plasmid containing human IGF-IR cDNA(A7(R)), or co-transfected with that containing only puromycin-resistant gene(A7(puro))were established in this study. Overexpression of IGF-IR resulted in the loss of necrotic zone in A7(R)spheroids, whereas spheroids of A7(puro)cells showed a central necrosis. Together with faster growth rate in the spheroids of A7(R)cells, it was suggested that tumors consisting cells with overexpression of IGF-IR grow faster with reduced formation of necrosis. A7(R)cells in spheroids, however, showed a higher radiosensitivity than A7(puro)cells and the radiosensitivity was dependent on a size of dose fraction.Role of IGF-IR in severely hypoxic cells was studied using fibroblasts derived from knockout mouse of IGF-IR(R-), or cells transfected with human IGF-IR cDNA(R+). (R+)cells survived longer than(R-)cells in a hypoxic condition of less than 3 mm Hg of partial oxygen pressure, and were more radioresistant than(R-)cells in the hypoxic condition. (R+)cells grown in confluent state exfoliated in a short time from the surface of petri dish, indicating that these cells tend to die rapidly depending on the cell density in a severely hypoxic condition.
期刊论文(108)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
佐々木武仁: "Chemoradiotherapy の生理学的基礎"肺癌の臨床. 2. 5-14 (1999)
Takehito Sasaki:“放化疗的生理学基础”肺癌的临床实践2. 5-14 (1999)。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Miura Masahiko: "Method in Molecular Biology, Vol.113: DNA Repair Protocols; Eukaryotic Systems, D.S. Henderson ed"Human Press Inc., Totowa, NJ, U.S.A. 6 (1999)
Miura Masahiko:“分子生物学方法,第 113 卷:DNA 修复方案;真核系统,D.S. Henderson 编辑”Human Press Inc.,Totowa,NJ,U.S.A. 6 (1999)
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
佐々木武仁: "Chemoradiotherapyの生物学的基礎"肺癌の臨床. 2. 5-14 (1999)
Takehito Sasaki:“放化疗的生物学基础”临床肺癌2. 5-14 (1999)。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
大川智彦、佐々木武仁 他7名: "放射線治療におけるQOL評価法の確立に関する研究-頭頸部癌患者-."日放腫会誌. 12. 395-398 (2000)
Tomohiko Okawa、Takehito Sasaki 等 7 人:“建立放射治疗中 QOL 评估方法的研究 - 日本放射治疗学会杂志”12. 395-398 (2000)。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Sasaki T: "Recent reappraisal on the effect of radiation in the low dose domain. In "Oral and Maxillofacial Radiology Today""H.Fuchihata ed., Elsevier Science B.V.. (2000)
Sasaki T:“最近重新评估低剂量领域辐射的影响。在“今日口腔颌面放射学”中”H.Fuchihata ed.,Elsevier Science B.V.(2000)
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
共 40 条
ELECTRONIC FILING AND APPLICATION OF INTRAORAL RADIOGRAPHIC IMAGES IN DENTAL INFORMATION SYSTEM
-
批准号:09557148
-
项目类别:Grant-in-Aid for Scientific Research (B)
-
资助金额:$6.98万
-
财政年份:1997
-
负责人:SASAKI Takehito
-
依托单位:
Role of PCNA in Repair of Radiation-induced DNA Damage
-
批准号:07457446
-
项目类别:Grant-in-Aid for Scientific Research (B)
-
资助金额:$4.42万
-
财政年份:1995
-
负责人:SASAKI Takehito
-
依托单位:
Microencapsulated Multicell Tumor Spheroids
-
批准号:01870085
-
项目类别:Grant-in-Aid for Developmental Scientific Research
-
资助金额:$8.96万
-
财政年份:1989
-
负责人:SASAKI Takehito
-
依托单位:
Quantitative Analysis on CT image in maxillofacial Region
-
批准号:01480463
-
项目类别:Grant-in-Aid for General Scientific Research (B)
-
资助金额:$4.35万
-
财政年份:1989
-
负责人:SASAKI Takehito
-
依托单位:
国内基金
海外基金
HDAC6-PRDX3-ROS信号轴调控卵巢癌 spheroid顺铂耐药的机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:10.0万元
-
批准年份:2021
-
负责人:孟凡良
-
依托单位:
CUDC-101联合cisplatin对卵巢癌腹水细胞spheroid形成及转移机制的相关研究
-
批准号:81402127
-
项目类别:青年科学基金项目
-
资助金额:21.0万元
-
批准年份:2014
-
负责人:孟凡良
-
依托单位: